Beating Versus Arrested Heart Isolated Tricuspid Valve Surgery: Long-term Outcomes.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 10 08 2020
revised: 22 02 2021
accepted: 15 03 2021
pubmed: 9 4 2021
medline: 4 2 2022
entrez: 8 4 2021
Statut: ppublish

Résumé

Isolated tricuspid valve (TV) surgery is a rare procedure generally considered at high risk for perioperative mortality and poor long-term outcomes. Surgical treatment can be performed with either an arrested heart (AH) or beating heart (BH) technique. The aim of this study was to compare the outcomes of isolated tricuspid surgery with 2 different approaches. The Surgical-Tricuspid Study is a multicenter international retrospective study enrolling adult patients who underwent isolated TV procedures (n = 406; age 56 ± 16 years; 56% female) at 13 international sites. The AH and BH strategies were performed in 253 and 153 patients, respectively. Propensity score-matched analysis was used to compare groups. After matching, 129 pairs were obtained and analyzed. The 30-day mortality rate was 6.2% versus 5.0% in the AH and BH groups, respectively (P = .9). The rates of acute renal failure requiring replacement therapy (10% versus 3%; P = .02) and stroke (1.6% versus 0%; P = .08) were numerically higher in the AH group. The 6-year survival rate was 67% ± 6% versus 78% ± 5% in the AH and BH groups, respectively (P = .18), whereas freedom from cardiac death was 75% ± 5% versus 84% ± 4% (P = .21). The 6-year composite cardiac end point of cardiac death and reoperation rate was 60% ± 9% versus 86% ± 5% (P = .024) comparing AH-TV replacement and BH-TV repair groups. Isolated TV surgery performed with a BH strategy is a safe option and resulted in a trend of increased long-term survival and freedom from reoperation compared with the standard AH technique. Patients undergoing BH valve repair had the best long-term outcome.

Sections du résumé

BACKGROUND BACKGROUND
Isolated tricuspid valve (TV) surgery is a rare procedure generally considered at high risk for perioperative mortality and poor long-term outcomes. Surgical treatment can be performed with either an arrested heart (AH) or beating heart (BH) technique. The aim of this study was to compare the outcomes of isolated tricuspid surgery with 2 different approaches.
METHODS METHODS
The Surgical-Tricuspid Study is a multicenter international retrospective study enrolling adult patients who underwent isolated TV procedures (n = 406; age 56 ± 16 years; 56% female) at 13 international sites. The AH and BH strategies were performed in 253 and 153 patients, respectively. Propensity score-matched analysis was used to compare groups.
RESULTS RESULTS
After matching, 129 pairs were obtained and analyzed. The 30-day mortality rate was 6.2% versus 5.0% in the AH and BH groups, respectively (P = .9). The rates of acute renal failure requiring replacement therapy (10% versus 3%; P = .02) and stroke (1.6% versus 0%; P = .08) were numerically higher in the AH group. The 6-year survival rate was 67% ± 6% versus 78% ± 5% in the AH and BH groups, respectively (P = .18), whereas freedom from cardiac death was 75% ± 5% versus 84% ± 4% (P = .21). The 6-year composite cardiac end point of cardiac death and reoperation rate was 60% ± 9% versus 86% ± 5% (P = .024) comparing AH-TV replacement and BH-TV repair groups.
CONCLUSIONS CONCLUSIONS
Isolated TV surgery performed with a BH strategy is a safe option and resulted in a trend of increased long-term survival and freedom from reoperation compared with the standard AH technique. Patients undergoing BH valve repair had the best long-term outcome.

Identifiants

pubmed: 33831392
pii: S0003-4975(21)00649-4
doi: 10.1016/j.athoracsur.2021.03.070
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-592

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Marco Russo (M)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria; Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, Rome, Italy. Electronic address: mar.russo1987@gmail.com.

Michele Di Mauro (M)

Cardio-Thoracic Surgery Unit, Heart and Vascular Centre, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.

Guglielmo Saitto (G)

Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, Rome, Italy; Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.

Antonio Lio (A)

Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, Rome, Italy; Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.

Paolo Berretta (P)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ancona, Italy.

Maurizio Taramasso (M)

Cardiac Surgery Department, University Heart Center of Zurich, Zurich, Switzerland.

Roberto Scrofani (R)

Cardiac Surgery Unit, Ospedale Fatenefratelli Sacco, Milano, Italy.

Alessandro Della Corte (A)

Department of Translational Medical Sciences, University of Campania "L. Vanvitelli," Unit of Cardiac Surgery, V Monaldi Hospital, Neaples, Italy.

Sandro Sponga (S)

Cardiac Surgery Unit, University Hospital of Udine, Udine, Italy.

Ernesto Greco (E)

Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological, and Geriatric Sciences, Sapienza University, Rome, Italy.

Matteo Saccocci (M)

Cardiac Surgery Unit, Poliambulanza Foundation Hospital, Brescia, Italy.

Antonio Calafiore (A)

Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Giacomo Bianchi (G)

Pasquinucci Heart Hospital, G. Monasterio Foundation, Massa, Italy.

Dror B Leviner (DB)

Carmel Medical Center, Haifa, Israel.

Andrea Biondi (A)

Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.

Ester Della Ratta (E)

Department of Translational Medical Sciences, University of Campania "L. Vanvitelli," Unit of Cardiac Surgery, V Monaldi Hospital, Neaples, Italy.

Ugolino Livi (U)

Cardiac Surgery Unit, University Hospital of Udine, Udine, Italy.

Erez Sharoni (E)

Carmel Medical Center, Haifa, Israel.

Paul Werner (P)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Carlo De Vincentiis (C)

Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.

Marco Di Eusanio (M)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ancona, Italy.

Alfred Kocher (A)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Carlo Antona (C)

Cardiac Surgery Unit, Ospedale Fatenefratelli Sacco, Milano, Italy.

Fabio Miraldi (F)

Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological, and Geriatric Sciences, Sapienza University, Rome, Italy.

Giovanni Troise (G)

Cardiac Surgery Unit, Poliambulanza Foundation Hospital, Brescia, Italy.

Marco Solinas (M)

Pasquinucci Heart Hospital, G. Monasterio Foundation, Massa, Italy.

Francesco Maisano (F)

Cardiac Surgery Department, University Heart Center of Zurich, Zurich, Switzerland.

Guenther Laufer (G)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Francesco Musumeci (F)

Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, Rome, Italy.

Martin Andreas (M)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH